264 related articles for article (PubMed ID: 21058191)
1. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.
deVere White RW; Tsodikov A; Stapp EC; Soares SE; Fujii H; Hackman RM
Nutr Cancer; 2010; 62(8):1036-43. PubMed ID: 21058191
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
4. Lycopene and soy isoflavones in the treatment of prostate cancer.
Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
[TBL] [Abstract][Full Text] [Related]
5. A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women.
Gleason CE; Carlsson CM; Barnet JH; Meade SA; Setchell KD; Atwood CS; Johnson SC; Ries ML; Asthana S
Age Ageing; 2009 Jan; 38(1):86-93. PubMed ID: 19054783
[TBL] [Abstract][Full Text] [Related]
6. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B
Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467
[TBL] [Abstract][Full Text] [Related]
7. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.
Gardner CD; Oelrich B; Liu JP; Feldman D; Franke AA; Brooks JD
Prostate; 2009 May; 69(7):719-26. PubMed ID: 19180569
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy.
Pendleton JM; Tan WW; Anai S; Chang M; Hou W; Shiverick KT; Rosser CJ
BMC Cancer; 2008 May; 8():132. PubMed ID: 18471323
[TBL] [Abstract][Full Text] [Related]
9. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.
Hazim S; Curtis PJ; Schär MY; Ostertag LM; Kay CD; Minihane AM; Cassidy A
Am J Clin Nutr; 2016 Mar; 103(3):694-702. PubMed ID: 26843154
[TBL] [Abstract][Full Text] [Related]
10. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.
Smith LJ; Kalhan R; Wise RA; Sugar EA; Lima JJ; Irvin CG; Dozor AJ; Holbrook JT;
JAMA; 2015 May; 313(20):2033-43. PubMed ID: 26010632
[TBL] [Abstract][Full Text] [Related]
11. Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration.
Akaza H; Miyanaga N; Takashima N; Naito S; Hirao Y; Tsukamoto T; Mori M
Jpn J Clin Oncol; 2002 Aug; 32(8):296-300. PubMed ID: 12411567
[TBL] [Abstract][Full Text] [Related]
12. Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.
Hamilton-Reeves JM; Banerjee S; Banerjee SK; Holzbeierlein JM; Thrasher JB; Kambhampati S; Keighley J; Van Veldhuizen P
PLoS One; 2013; 8(7):e68331. PubMed ID: 23874588
[TBL] [Abstract][Full Text] [Related]
13. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian men.
Hedlund TE; Maroni PD; Ferucci PG; Dayton R; Barnes S; Jones K; Moore R; Ogden LG; Wähälä K; Sackett HM; Gray KJ
J Nutr; 2005 Jun; 135(6):1400-6. PubMed ID: 15930444
[TBL] [Abstract][Full Text] [Related]
14. Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men.
Nagata Y; Sugiyama Y; Fukuta F; Takayanagi A; Masumori N; Tsukamoto T; Akasaka H; Ohnishi H; Saitoh S; Miura T; Moriyama K; Tsuji H; Akaza H; Mori M
Int Urol Nephrol; 2016 Sep; 48(9):1453-60. PubMed ID: 27262851
[TBL] [Abstract][Full Text] [Related]
15. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
17. Distribution of isoflavones in samples of serum, liver and mammary glands of rats or pigs fed dietary isoflavones.
Gilani GS; Farmer C; Dyck M; Robertson P; Dahiya J; Sepehr E; Fan L; Nicolidakis H; Curran I; Cooke GM
Ann Nutr Metab; 2011; 58(3):171-80. PubMed ID: 21654164
[TBL] [Abstract][Full Text] [Related]
18. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits.
Yamakoshi J; Piskula MK; Izumi T; Tobe K; Saito M; Kataoka S; Obata A; Kikuchi M
J Nutr; 2000 Aug; 130(8):1887-93. PubMed ID: 10917898
[TBL] [Abstract][Full Text] [Related]
19. Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.
van der Velpen V; Geelen A; Hollman PC; Schouten EG; van 't Veer P; Afman LA
Am J Clin Nutr; 2014 Nov; 100(5):1269-77. PubMed ID: 25332325
[TBL] [Abstract][Full Text] [Related]
20. A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.
Kumar NB; Krischer JP; Allen K; Riccardi D; Besterman-Dahan K; Salup R; Kang L; Xu P; Pow-Sang J
Nutr Cancer; 2007; 59(2):163-8. PubMed ID: 18001210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
